Before-treatment body mass index as a prognostic factor in cancer patients receiving immune checkpoint inhibitors: a systematic review and dose-response meta-analysis
Pretreatment body mass index (BMI) has been associated with outcomes during immune checkpoint inhibitor (ICI) therapy, but study-specific categories and incomplete adjustment complicate interpretation. We evaluated associations with efficacy and toxicity across tumor types and BMI definitions. We searched...